resveratrol has been researched along with nadp in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Chen, J; Lee, WB | 1 |
| Attar, BM; Atten, MJ; Holian, O; Wahid, S | 1 |
| Bernhard, D; Crazzolara, R; Csordas, A; Kofler, R; Schwaiger, W; Tinhofer, I | 1 |
| López-Novoa, JM; Mayoral, P; Morales, AI; Pérez-Barriocanal, F; Rodríguez-Barbero, A; Vicente-Sánchez, C | 1 |
| Chen, JK; Chow, SE; Hshu, YC; Wang, JS | 1 |
| Chapple, S; Collins, C; Fairman, DA | 1 |
| Akar, F; Sepici, A; Soylemez, S | 1 |
| Akar, F; Gokalp, B; Ozturk, K; Pektas, MB; Sepici, A; Soylemez, S; Surucu, HS; Tufan, C; Ulus, AT | 1 |
| Harada, N; Inui, H; Isayama, A; Ito, Y; Mitani, T; Nakano, Y; Takenaka, S; Tanimori, S; Yamaji, R | 1 |
| Ahn, KS; Hong, SH; Kim, SH; Ko, HS; Lee, HJ; Shim, BS; Sohn, EJ | 1 |
| Alka, K; Dolly, JO; Henehan, GT; Ryan, BJ | 1 |
| Bedard, K; Chen, PL; Greenshields, AL; Hoskin, DW; Nightingale, M; Whitehouse, S | 1 |
| Baj, F; Baravalle, R; Ciaramella, A; Di Nardo, G; Gilardi, G | 1 |
| Absy, S; Casati, MZ; Cirano, FR; Corrêa, MG; Pimentel, SP; Ribeiro, FV; Tenenbaum, H | 1 |
| Chen, YY; Cheng, PW; Ho, CY; Sun, GC; Tseng, CJ; Wu, TT; Yeh, TC | 1 |
15 other study(ies) available for resveratrol and nadp
| Article | Year |
|---|---|
Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Topics: Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; NADP; Oxazines; Recombinant Proteins; Resveratrol; Stilbenes; Substrate Specificity | 2001 |
Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; DNA; Humans; Hydrogen Peroxide; Ionomycin; Ionophores; NADP; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxidants; Protein Kinase C; Reactive Oxygen Species; Resveratrol; Stilbenes; Stomach Neoplasms; Superoxides; Tumor Cells, Cultured | 2002 |
Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells.
Topics: Antioxidants; Apoptosis; Artifacts; Cell Division; Colorimetry; Dose-Response Relationship, Drug; Electron Transport; Formazans; Growth Inhibitors; Histocytochemistry; Humans; Indicators and Reagents; Leukemia, T-Cell; Mitochondria; NAD; NADP; Organ Specificity; Oxidation-Reduction; Resveratrol; Stilbenes; Subcellular Fractions; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Resveratrol inhibits gentamicin-induced mesangial cell contraction.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Cell Size; Cells, Cultured; Enzyme Inhibitors; Gentamicins; Glomerular Mesangium; Muscle Contraction; Muscle, Smooth; NADP; NADPH Oxidases; Rats; Resveratrol; Stilbenes | 2006 |
Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages.
Topics: Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Humans; Lipoproteins, LDL; NADP; Oxidative Stress; Resveratrol; Stilbenes | 2007 |
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Models, Biological; NADP; Paroxetine; Pyrazines; Resveratrol; Stilbenes; Theophylline; Thiones; Thiophenes | 2007 |
Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats.
Topics: Acetylcholine; Angiotensin II; Animals; Antioxidants; Endothelium, Vascular; Female; Male; NAD; NADP; Nitric Oxide; Phenylephrine; Rats; Resveratrol; Sex Factors; Stilbenes; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Wine | 2009 |
Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
Topics: Acetylcholine; Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Estrogens; Insulin; Lipid Peroxides; Lipids; Male; NADP; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rabbits; Resveratrol; Stilbenes; Superoxide Dismutase; Testosterone; Time Factors; Vascular Diseases | 2011 |
Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene.
Topics: Alcohol Oxidoreductases; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Binding, Competitive; Breast Neoplasms; Chromatography, Affinity; Doxorubicin; Female; Humans; Hydroquinones; MCF-7 Cells; NADP; Phytotherapy; Plant Extracts; Protein Binding; Resveratrol; Stilbenes | 2013 |
Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.
Topics: Animals; Antioxidants; Calcium Oxalate; Cell Movement; Cell Survival; Cells, Cultured; Chemokine CCL2; Down-Regulation; Ethylene Glycol; Humans; Hyaluronic Acid; Kidney; Kidney Calculi; Male; Malondialdehyde; NADP; NADPH Oxidases; Osteopontin; Oxalic Acid; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Transforming Growth Factors; Wound Healing | 2013 |
New inhibitors of the Kvβ2 subunit from mammalian Kv1 potassium channels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain; Catechols; Cortisone; Kinetics; NADP; Oxidation-Reduction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Resveratrol; Rutin; Shaker Superfamily of Potassium Channels; Stilbenes; Valproic Acid | 2014 |
Resveratrol, piperine and apigenin differ in their NADPH-oxidase inhibitory and reactive oxygen species-scavenging properties.
Topics: Alkaloids; Antioxidants; Apigenin; Benzodioxoles; Cell Line; Humans; Hydrogen Peroxide; NADP; NADPH Oxidases; Oxidation-Reduction; Pentacyclic Triterpenes; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Reactive Oxygen Species; Resveratrol; Stilbenes; Triterpenes | 2016 |
Identification of endocrine disrupting chemicals acting on human aromatase.
Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Benzhydryl Compounds; Biological Assay; Endocrine Disruptors; Enzyme-Linked Immunosorbent Assay; Estrone; Gene Expression; Humans; Ketoconazole; Ligands; NADP; Nicotine; Nitriles; Phenols; Protein Binding; Recombinant Proteins; Resveratrol; Sildenafil Citrate; Small Molecule Libraries; Stilbenes; Triazoles | 2018 |
Resveratrol attenuates oxidative stress during experimental periodontitis in rats exposed to cigarette smoke inhalation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cigarette Smoking; Enzyme-Linked Immunosorbent Assay; Gingiva; Male; Mandible; Molar; NADP; Oxidative Stress; Periodontitis; Polymerase Chain Reaction; Rats, Wistar; Resveratrol; RNA, Messenger; Sirtuin 1; Superoxide Dismutase-1 | 2019 |
Blocking of SGLT2 to Eliminate NADPH-Induced Oxidative Stress in Lenses of Animals with Fructose-Induced Diabetes Mellitus.
Topics: Animals; Cataract; Diabetes Mellitus; Fructose; Metformin; NADP; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Resveratrol; Sodium-Glucose Transporter 2 | 2022 |